132 related articles for article (PubMed ID: 16392308)
41. Recurrent small intestinal ileus secondary to valsartan treatment.
Saadi T; Brun R; Chowers Y; Baruch Y; Waterman M
J Clin Gastroenterol; 2014; 48(5):462-3. PubMed ID: 24296424
[No Abstract] [Full Text] [Related]
42. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
[TBL] [Abstract][Full Text] [Related]
43. Two episodes of anuria and acute pulmonary edema in a losartan-treated patient with solitary kidney.
Kiykim AA; Boz M; Ozer C; Camsari A; Yildiz A
Heart Vessels; 2004 Jan; 19(1):52-4. PubMed ID: 14685757
[TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
Zhu S; Liu Y; Wang L; Meng QH
Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891
[TBL] [Abstract][Full Text] [Related]
45. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
Li PK; Leung CB; Chow KM; Cheng YL; Fung SK; Mak SK; Tang AW; Wong TY; Yung CY; Yung JC; Yu AW; Szeto CC;
Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
[TBL] [Abstract][Full Text] [Related]
46. Acute renal failure induced by an angiotensin II receptor antagonist in a 14-year-old boy with reflux nephropathy.
Fujinaga S; Kaneko K; Ohtomo Y; Yamashiro Y
Pediatr Nephrol; 2006 Apr; 21(4):601-2. PubMed ID: 16534606
[No Abstract] [Full Text] [Related]
47. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
[TBL] [Abstract][Full Text] [Related]
48. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Esaki M; Kanamori H; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
J Card Fail; 2007 Mar; 13(2):155-62. PubMed ID: 17395057
[TBL] [Abstract][Full Text] [Related]
49. Severe neonatal renal failure after maternal use of angiotensin II type I receptor antagonists.
Sinelli MT; Cattarelli D; Cortinovis S; Maroccolo D; Chirico G
Pediatr Med Chir; 2008; 30(6):306-8. PubMed ID: 19431954
[TBL] [Abstract][Full Text] [Related]
50. Linear lichenoid drug eruption induced by valsartan.
Gencoglan G; Ceylan C; Kazandi AC
Clin Exp Dermatol; 2009 Oct; 34(7):e334-5. PubMed ID: 19456765
[No Abstract] [Full Text] [Related]
51. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
Rump LC; Baranova E; Okopien B; Weisskopf M; Kandra A; Ferber P
Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
[TBL] [Abstract][Full Text] [Related]
52. Fetal toxicity of valsartan and possible reversible adverse side effects.
Berkane N; Carlier P; Verstraete L; Mathieu E; Heim N; Uzan S
Birth Defects Res A Clin Mol Teratol; 2004 Aug; 70(8):547-9. PubMed ID: 15329835
[TBL] [Abstract][Full Text] [Related]
53. Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus.
Hollenberg NK; Parving HH; Viberti G; Remuzzi G; Ritter S; Zelenkofske S; Kandra A; Daley WL; Rocha R
J Hypertens; 2007 Sep; 25(9):1921-6. PubMed ID: 17762658
[TBL] [Abstract][Full Text] [Related]
54. Drug-induced isolated visceral angioneurotic edema.
Arakawa M; Murata Y; Rikimaru Y; Sasaki Y
Intern Med; 2005 Sep; 44(9):975-8. PubMed ID: 16258215
[TBL] [Abstract][Full Text] [Related]
55. Ask the doctor. I read that angiotensin-receptor blockers cause cancer. I take one (Diovan) for my blood pressure. Should I stop?
Lee T
Harv Heart Lett; 2010 Dec; 21(4):8. PubMed ID: 21218537
[No Abstract] [Full Text] [Related]
56. Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex.
Bork K; Dewald G
Am J Med; 2004 May; 116(9):644-5. PubMed ID: 15093766
[No Abstract] [Full Text] [Related]
57. [Successful mega studies with heart patients. Valsartan possesses cardioprotective action].
MMW Fortschr Med; 2006 Feb; 148(5):48-9. PubMed ID: 16518941
[No Abstract] [Full Text] [Related]
58. Safety concerns of angiotensin II receptor blockers in preschool children.
Tullus K
Arch Dis Child; 2011 Sep; 96(9):881-2. PubMed ID: 21690106
[TBL] [Abstract][Full Text] [Related]
59. Acute renal failure during lisinopril and losartan therapy for proteinuria.
Hanevold CD
Pharmacotherapy; 2006 Sep; 26(9):1348-51. PubMed ID: 16945058
[TBL] [Abstract][Full Text] [Related]
60. Acute renal failure after administration of losartan.
Lamb RV; Walton T
W V Med J; 1996; 92(5):241. PubMed ID: 8918197
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
